Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate by CFDA

By: via Benzinga
Sinovac Biotech Ltd. (NASDAQ: SVA) today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.